More on CMPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/3/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Compass Therapeutics, Inc (NQ:CMPX)
Delayed: 5.51 -0.02 (0.36%)
Prev. Close $5.53  
Open$5.41 
52 Wk High$ 
52 Wk Low$ 
Day High$5.53 
Day Low$5.29 
P/E N/A  
EPS$ 
Volume1,845,034 

Friends, Peers and Foes (?): ABBV, AMGN, ARGX, ARWR, AVTX (more...)

Mar 5, 2026 05:32 PM Compass Therapeutics, Inc. (CMPX) Tops Q4 EPS by 1c
Mar 5, 2026 04:33 PM Compass Therapeutics (CMPX) PT Raised to $9 at Jefferies
Mar 5, 2026 11:37 AM William Blair Reiterates Outperform Rating on Compass Therapeutics (CMPX)
Mar 5, 2026 11:18 AM Raymond James Reiterates Outperform Rating on Compass Therapeutics (CMPX) following Q4 results
Mar 5, 2026 07:31 AM Form 10-K Compass Therapeutics, For: Dec 31
Mar 5, 2026 07:31 AM Form 8-K Compass Therapeutics, For: Mar 05
Mar 5, 2026 07:30 AM Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update
Mar 2, 2026 05:31 PM Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight
Feb 13, 2026 04:31 PM Form SCHEDULE 13G/A Compass Therapeutics, Filed by: Blackstone Holdings II L.P.
Feb 13, 2026 08:20 AM Craig-Hallum Starts Compass Therapeutics (CMPX) at Buy
View All Articles

Entities mentioned with CMPX

View All Entities